Study Phase 3

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17deacetyl-norgestimate and Ethinyl Estradiol

Trial Information

Generic NameNorelgestrominProduct NameMONONESSA ® ORTHO-CYCLEN ® ORTHO TRI-CYCLEN ® TRINESSA ®Therapeutic AreaGenito Urinary System and Sex HormonesProduct ClassSex Hormones and Modulators of the Genital SystemPharmacological SubgroupHormonal Contraceptives for Systemic UseChemical SubgroupProgestogens and Estrogens, Sequential PreparationsCondition StudiedContraception
Sponsor Protocol NumberNRGEEP-CONT-002Enrollment1751Data PartnerJohnson & Johnson% Female100%Mean/Median Age (Years)28.7% White91%

Supporting Documentation

  • Collected Datasets Available
  • Protocol with Amendments Available
  • Statistical Analysis Plan Available

Approved Data Requests Associated with this Trial

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.